Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03231852 · ClinicalTrials.gov registry record
Patient Perceptions and Willingness to Enroll in Clinical Trials
A clinical trial of Cancer Clinical Trials, sponsored by University of Virginia.
- Completed
- Registry status
- 166
- Enrollment target
- 1
- Study location
NCT03231852: Completed study of Cancer Clinical Trials, sponsored by University of Virginia.
NCT03231852 is a study of Cancer Clinical Trials that has completed, run by University of Virginia. The registered enrollment target is 166 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03231852, a study of Cancer Clinical Trials, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 166 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of our study is to determine which factors affect willingness to participate in gynecologic oncology clinical trials. Women with a diagnosis of gynecologic malignancy will be approached to complete a survey assessing willingness to participate in clinical trials. The validated Attitudes and Randomized Trials Questionnaire (ARTQ) will be used to assess willingness to participate.
Primary Outcome
Bivariate outcome derived from ARTQ survey
Conditions Studied
Interventions
- OTHER Survey
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2017-06-15 |
| Est. Completion | 2018-05-01 |
What the finished NCT03231852 record still lists
NCT03231852 is an observational study that tracks outcomes without assigning an intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Cancer Clinical Trials appearing as the primary indexed condition, and to 1 intervention - of which Survey is the first listed.
NCT03231852 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT03231852 about?
NCT03231852 is a clinical study titled "Patient Perceptions and Willingness to Enroll in Clinical Trials". The objective of our study is to determine which factors affect willingness to participate in gynecologic oncology clinical trials. Women with a diagnosis of gynecologic malignancy will be approached to complete a survey assessing willingness to participate in clinical trials. The validated Attitude...
What is the current status of trial NCT03231852?
This trial is currently completed. The enrollment target is 166 participants. The study started on 2017-06-15. Estimated completion is 2018-05-01.
What conditions does trial NCT03231852 study?
This clinical trial studies the following conditions: Cancer Clinical Trials.
What interventions are being tested in trial NCT03231852?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT03231852?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03231852 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Clinical Trials
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI